IL267243A - Heparanase inhibitors and use thereof - Google Patents
Heparanase inhibitors and use thereofInfo
- Publication number
- IL267243A IL267243A IL267243A IL26724319A IL267243A IL 267243 A IL267243 A IL 267243A IL 267243 A IL267243 A IL 267243A IL 26724319 A IL26724319 A IL 26724319A IL 267243 A IL267243 A IL 267243A
- Authority
- IL
- Israel
- Prior art keywords
- heparanase inhibitors
- heparanase
- inhibitors
- Prior art date
Links
- 102100024025 Heparanase Human genes 0.000 title 1
- 108010037536 heparanase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662433639P | 2016-12-13 | 2016-12-13 | |
| AU2017902346A AU2017902346A0 (en) | 2017-06-20 | Methods of treating ocular disorders | |
| PCT/AU2017/000271 WO2018107201A1 (en) | 2016-12-13 | 2017-12-13 | Heparanase inhibitors and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL267243A true IL267243A (en) | 2019-08-29 |
Family
ID=67148292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL267243A IL267243A (en) | 2016-12-13 | 2019-06-11 | Heparanase inhibitors and use thereof |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3555071A4 (en) |
| AU (2) | AU2017376818A1 (en) |
| IL (1) | IL267243A (en) |
| WO (1) | WO2018107201A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12285407B2 (en) | 2018-11-21 | 2025-04-29 | The University Of The West Indies | Bis-indolylmethane derivatives and uses thereof |
| CN118852197B (en) * | 2024-06-27 | 2025-09-05 | 常州康安生物科技有限公司 | Apigenin derivative and its preparation method and application |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4668787A (en) * | 1985-12-20 | 1987-05-26 | Ortho Pharmaceutical Corporation | 5,6-dialkoxy-4-imino-2(1H)quinazolinone derivatives |
| EP0594877A1 (en) * | 1992-10-26 | 1994-05-04 | National Science Council | Imidazo(1,2-c)quinazoline derivates as antihyper tensives and anti dysurics |
| GT199900185A (en) * | 1998-11-06 | 2001-04-18 | NOVEDOSA PIRIMIDIN-4-ENAMINE AS A FUNGICIDE. | |
| ATE468336T1 (en) * | 2002-03-15 | 2010-06-15 | Vertex Pharma | AZOLYLAMINOAZINE AS PROTEIN KINASE INHIBITORS |
| US7928111B2 (en) * | 2007-06-08 | 2011-04-19 | Senomyx, Inc. | Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors |
| KR101646960B1 (en) * | 2007-10-16 | 2016-08-09 | 프로젠 피지500 시리즈 피티와이 리미티드 | Novel sulfated oligosaccharide derivatives |
-
2017
- 2017-12-13 EP EP17880657.6A patent/EP3555071A4/en not_active Withdrawn
- 2017-12-13 WO PCT/AU2017/000271 patent/WO2018107201A1/en not_active Ceased
- 2017-12-13 AU AU2017376818A patent/AU2017376818A1/en not_active Abandoned
-
2019
- 2019-06-11 IL IL267243A patent/IL267243A/en unknown
-
2022
- 2022-03-11 AU AU2022201731A patent/AU2022201731B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018107201A1 (en) | 2018-06-21 |
| AU2022201731B2 (en) | 2024-03-28 |
| EP3555071A4 (en) | 2020-06-10 |
| AU2022201731A1 (en) | 2022-04-07 |
| EP3555071A1 (en) | 2019-10-23 |
| AU2017376818A1 (en) | 2019-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265922A (en) | Tyk2 inhibitors and uses thereof | |
| IL266109A (en) | Tyk2 inhibitors and uses thereof | |
| IL261606A (en) | Substituted inhibitors of menin-mll and methods of use | |
| IL267291B (en) | Ectonucleotidase inhibitors and methods of use thereof | |
| SG11202000714QA (en) | Tyk2 inhibitors and uses thereof | |
| GB201605126D0 (en) | Inhibitors and their uses | |
| IL282482A (en) | Protoxin-ii variants and methods of use | |
| GB201615282D0 (en) | Tankyrase inhibitors | |
| IL258500A (en) | Combination therapy with glutaminase inhibitors and immuno-oncology agents | |
| IL267238A (en) | Heparanase inhibitors and use thereof | |
| SMT202300256T1 (en) | Lrrc33 inhibitors and use thereof | |
| SMT202300381T1 (en) | Lsd1 inhibitors and medical uses thereof | |
| IL282508A (en) | Protoxin-ii variants and methods of use | |
| IL254916B (en) | Inhibitors and their uses | |
| IL255530A (en) | Efflux-pump inhibitors and therapeutic uses thereof | |
| IL251077B (en) | Integrin inhibitors and their use | |
| IL251078A0 (en) | Integrin inhibitors and their use | |
| IL267243A (en) | Heparanase inhibitors and use thereof | |
| ZA201803212B (en) | Gelatinase inhibitors and use thereof | |
| GB201509977D0 (en) | Dispensers and methods of use thereof | |
| GB2545167B (en) | Cloches and use thereof | |
| GB201505975D0 (en) | Inhibitors and their uses | |
| GB201505971D0 (en) | Inhibitors and their uses | |
| AU2014900775A0 (en) | Heparanase inhibitors and uses thereof | |
| GB201404335D0 (en) | Selective glycosidase inhibitors and uses thereof |